Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer

E-ISSN： 1097-0215|137|3|512-524

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.3, 2015-08, pp. : 512-524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Invariant NKT cell serves as a novel therapeutic target for control of obesity

By Iwabuchi Kazuya Satoh Masashi

Clinical Lipidology, Vol. 8, Iss. 1, 2013-02 ,pp. : 51-54

Future Medicine

Access to resources Recommend Favorite

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J. Ricci Jr. Andrew

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite

HER2/neu vaccines in breast cancer

By Khoo Steven Ponniah Sathibalan Peoples George E

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 217-223

Future Medicine

Access to resources Recommend Favorite

The Predictive Value of HER2 in Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 73-82

Karger

Access to resources Recommend Favorite

HER2 as a Prognostic Factor in Breast Cancer

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 67-72

Karger

Access to resources Recommend Favorite